Retinal functional and structural changes in patients with Parkinson's disease
Rehab Elanwar1, Hatem Al Masry2, Amna Ibrahim2
1Neuro Diagnostic Research Center, Beni-Suef University, Beni-Suef, Egypt.
BMC Neurology
|September 18, 2023
Summary
Parkinson's disease (PD) patients show significant retinal structural and functional changes, including reduced retinal nerve fiber layer thickness and impaired electroretinogram responses. These changes correlate with disease duration and motor dysfunction severity.
Area of Science:
- Ophthalmology
- Neurology
- Neuroscience
Background:
- Visual dysfunction is a common non-motor symptom in Parkinson's disease (PD).
- Retinal changes may serve as an indicator of neurodegeneration in PD.
- Understanding these changes can offer insights into disease progression.
Purpose of the Study:
- To assess functional and structural retinal alterations in PD patients.
- To investigate the correlation between retinal changes, disease duration, and motor impairment.
- To compare retinal parameters in PD patients with age- and sex-matched healthy controls.
Main Methods:
- A case-control study involving 50 idiopathic PD patients and 50 healthy controls (aged 50-80).
- Motor function assessed using Hoehn and Yahr staging and UPDRS.
- Retinal structure evaluated via Optical Coherence Tomography (OCT) and function via full-field electroretinogram (ff-ERG).
Main Results:
- PD patients exhibited significantly reduced peripapillary retinal nerve fiber layer (RNFL) thickness and macular ganglion cell complex (GCC) thickness compared to controls (P<0.05).
- ff-ERG revealed significantly delayed latencies and reduced amplitudes in both rod and cone responses in PD patients (P<0.001).
- Negative correlations found between disease duration and RNFL thickness, and between UPDRS scores and ff-ERG parameters.
Conclusions:
- Significant structural and functional retinal impairments are present in Parkinson's disease patients.
- Retinal thickness is significantly affected by disease duration.
- Motor dysfunction severity in PD correlates negatively with retinal function.
Related Concept Videos
Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
Parkinson's Disease: Overview
592
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
592
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K


